Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents.

MLA

Abdullahi, Sagiru Hamza, et al. “Computational Modeling, Ligand-Based Drug Design, Drug-Likeness and ADMET Properties Studies of Series of Chromen-2-Ones Analogues as Anti-Cancer Agents.” Bulletin of the National Research Centre, vol. 46, no. 1, June 2022, pp. 1–25. EBSCOhost, https://doi.org/10.1186/s42269-022-00869-y.

APA

Abdullahi, S. H., Uzairu, A., Shallangwa, G. A., Uba, S., & Umar, A. B. (2022). Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents. Bulletin of the National Research Centre, 46(1), 1–25. https://doi.org/10.1186/s42269-022-00869-y

Chicago

Abdullahi, Sagiru Hamza, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba, and Abdullahi Bello Umar. 2022. “Computational Modeling, Ligand-Based Drug Design, Drug-Likeness and ADMET Properties Studies of Series of Chromen-2-Ones Analogues as Anti-Cancer Agents.” Bulletin of the National Research Centre 46 (1): 1–25. doi:10.1186/s42269-022-00869-y.